Verzenio is available as a 50 mg, 100 mg, 150 mg, and 200 mg oral tablet with recommended dosing of 150 mg twice daily when given in combination with fulvestrant and 200 mg twice daily when given alone. The average wholesale price (AWP) per tablet is $234.60. NPS is planning to review Verzenio for placement on the national formularies. For additional details on Verzenio, please view the FDAâs press release.
TUESDAY, Oct. 20 (HealthDay News) -- New research raises doubts about the long-held medical dogma that dangerous blood clots in the lungs, known as pulmonary emboli, originate from clots in the deep veins of the legs or other parts of the lower body, which then break up and travel up through the body.
Disorders of blood cells (for instance sickle cell disease) or blood proteins can increase the chance of thrombus formation and therefore contribute to the risk of ischemic stroke. An embolus is most often a piece of a thrombus that has broken free and is carried toward the brain by the bloodstream. The term thromboembolus is used a lot because it turns out that most emboli arise from thrombi. However, bits of plaque, fat, air bubbles, and other material also qualify as emboli. Presumably an embolus floats along with the flowing blood until it encounters a narrowing in an artery through which it cannot pass.